We Are Testing® Post-HPCI India 2026 Webinar: Trends in Cosmetic Testing

Webinaire : Tendances des tests indiens 2026
Webinaire : Tendances des tests indiens 2026

Following HPCI India 2026 in Mumbai, We Are Testing® is excited to announce a post-show webinar dedicated to the latest cosmetic and dermocosmetic testing trends observed at the event. This online session brings together key insights from the exhibition floor and expands them for a global audience of cosmetic professionals, R&D teams, and innovation leaders.

The webinar will dive into regional testing priorities, methodology innovations, and real case examples from laboratories and partners who participated in HPCI India. Whether you attended the show or not, this session is an opportunity to connect with experts and stay informed about evolving testing strategies shaping the market.

Post-Show Webinar: HPCI India Testing Trends

📌 Topic: Key Testing Trends & Innovations Observed at HPCI India 2026
📍 Time: February 5th, 2026 at 10:00AM [CET]
🔗 Registration: https://us06web.zoom.us/webinar/register/8517684678599/WN_R31luws4Sw2jxmO5VrX4fg

This webinar is part of the We Are Testing® post-show webinar series, designed to deliver regional testing insights to cosmetic professionals who couldn’t attend trade shows in person. These sessions cover local market needs, scientific evaluation methods, and approaches used by testing labs present at the exhibition.

The speakers

PRZYBYLSKI Julie – Marketing and communication·Pixience

Advancing cosmetic testing with C-Cube: reliable image and evaluation to validate claims

The demand for objective, reproducible data in cosmetic research continues to grow, particularly as product claims become more specific and science-driven. In this context, imaging is no longer a support tool, it plays a central role in demonstrating efficacy with clarity and credibility. Pixience has developed the C-Cube Clinical Research system to meet this need: a compact, high-resolution imaging solution designed to support the evaluation of both skin and scalp-related parameters, in line with real-world clinical workflows. Thanks to its calibrated acquisition, automation features, and integrated analysis capabilities, the C-Cube helps translate visual changes into measurable outcomes. This presentation will highlight the role of standardized imaging in cosmetic protocols and share insights into how emerging technologies are reshaping the future of skin evaluation. Pixience provides advanced imaging solutions for clinical research. With a strong focus on precision and objectivity, the C-Cube imager allows brands and CROs evaluate product efficacy through standardized and reproducible imaging. It delivers high-resolution 2D and 3D images for assessing skin, scalp, and hair parameters. Built on validated metrics and scientific rigor, the C-Cube enables autonomous data collection and supports a wide range of cosmetic claims: colorimetry, prolilometry, hair analysis, ex-vivo, spectral analysis. Trusted by major industry players, Pixience is a key partner for delivering robust visual evidence in dermocosmetic and pharmaceutical research.

CHARPENTIER Anne – CEO & Founder·Skinobs

As the Indian cosmetics industry continues to thrive at the crossroads of tradition, innovation, and advanced science, Asia has become a global powerhouse for skincare expertise and testing excellence. In connection with HPCI India 2026, this webinar will explore the key testing trends shaping the Indian beauty landscape and how the region’s unique scientific and cultural perspectives are redefining global standards. Skinobs will highlight how brands, laboratories, and research institutes across India are combining cutting-edge in vivo, in vitro, and ex vivo methodologies with holistic approaches inspired by wellness, balance, and preventive care. Special attention will be given to skin tone and texture evaluation, sensitivity and soothing claims, sun protection testing, and biotech-driven ingredient validation, areas where Asia continues to lead innovation. The session will also spotlight the integration of AI-powered skin analysis, personalized testing protocols, and eco-responsible methodologies rooted in local biodiversity and traditional ingredients. Ultimately, this webinar will show how these testing innovations reflect India’s distinctive vision of beauty, centered on harmony, efficacy, and long-term skin health—while strengthening the credibility, sustainability, and global competitiveness of the region’s cosmetics industry, as celebrated at HPCI India 2026. Voir Plus

Dr. Annie Jain – Managing Director·CIDP India

Inclusive Beauty: Validating Claims Across Skin Types, Pollution Exposure and Microbiomes with CIDP

As the beauty industry evolves to meet the needs of a more diverse global population, the importance of inclusive clinical research has never been greater. Join Dr. Annie Jain, Managing Director of CIDP India, for a power-packed 10-minute session on future-proofing your beauty brand through truly inclusive and cutting-edge dermocosmetic research. CIDP India, with its dedicated state-of-the-art unit in Delhi excels in real-life anti-pollution studies, acne, post-inflammatory hyperpigmentation (PIH) and pigmentary disorders, as well as advanced biological sampling for in-depth skin and scalp biofilm and microbiome analysis. From safety assessments (HRIPT, comedogenicity), clinical efficacy studies in atopic dermatitis, seborrheic dermatitis, psoriasis and eczema, to hair care, colour cosmetics, large-scale observational studies and consumer perception research, CIDP India delivers end-to-end solutions with scientific rigour and regulatory-ready dossiers. Drawing on CIDP’s international presence and the extensive volunteer base of 38,000+ participants worldwide (including 10,000+ in India), this session will highlight how studies encompassing Fitzpatrick Phototypes I–VI globally and III–VI in India provide valuable insights into product performance across different skin tones and environmental conditions. Future-proof your innovations with data that capture skin type variation, pollution exposure, and consumer realities, because inclusive, credible science is the new benchmark for beauty.

Guillaume Lejeune – Business Development Officer·Weneos

In recent months, numerous changes have been made to the methods for assessing sun protection. Here is an overview of the regulations in force in Asia. Since its creation in 1999, WENEOS has established itself as the benchmarks laboratory specialized in sunscreen testing for cosmetic products. As the leader in the development of alternative methods, WENEOS is actively invovled in the leaboration of international standards. 

What You’ll Learn

During the session, expert speakers will explore:

  • Emerging testing priorities in the Indian cosmetic market, based on exchanges and demonstrations from HPCI India 2026 participants.
  • Methodological innovations in clinical, instrumental, and consumer testing highlighted during the show.
  • Case studies and service overviews from co-exhibitors, sponsors, and other specialists present at the event.
  • Practical guidance on connecting with laboratories and testing partners to support product development and claims substantiation.

Why Attend This Webinar

The We Are Testing® webinar series is created to extend the impact of trade shows beyond the physical event and provide valuable content for a global audience. Whether you’re a brand seeking new testing partners or an R&D manager tracking regional evaluation trends, the webinar will deliver:

  • Actionable insights into current testing priorities
  • Market-specific trends, including regulatory and consumer expectations
  • A chance to engage with testing experts who were on the ground in Mumbai
  • Access to knowledge shared at the show, without travel constraints.

These post-show webinars are free and promoted to thousands of industry professionals across Skinobs’ network of verified cosmetic experts, formulators, and decision-makers.

Join Us Online

Don’t miss this opportunity to extend your event learning, explore trends in cosmetic evaluation, and stay at the forefront of testing innovations emerging from HPCI India 2026.